Clinical trial
Magnetic Resonance Imaging (MRI) Staging of Cervix Cancer
NCT00193934 · Trans Tasman Radiation Oncology Group, Other · Completed
Key facts
| NCT number | NCT00193934 |
|---|---|
| Title | Magnetic Resonance Imaging (MRI) Staging of Cervix Cancer |
| Official title | Prospective Study to Determine the Relationships Between Survival and FIGO Stage, Tumour Volume and Corpus Invasion in Cervical Cancer |
| Lead sponsor | Trans Tasman Radiation Oncology Group, Other |
| Collaborators | Peter MacCallum Cancer Centre, Australia |
| Status | Completed |
| Study type | Observational |
| Conditions | Cancer of the Uterine Cervix |
| Enrollment | 109 |
| Start date | Jan 1, 2006 |
| Primary completion | May 1, 2014 |
| Completion | May 15, 2014 |
| First posted | Sep 19, 2005 |
| Last update posted | Jul 12, 2017 |
| Countries | Australia, India, New Zealand, Singapore, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: